CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 403 enrolled
Drug / intervention
Systematic evaluation by an ID expert.behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02951481
NCT02951481N/ACompleted

Antimicrobial Stewardship Program Based on the Detection and Monitoring of Patients With Clostridium Difficile Infection (PACTA-ICD)

José María Aguado García, MD, PhD·observational·Posted Nov 1, 2016·Updated Apr 1, 2022

In Brief

An observational study evaluating Systematic evaluation by an ID expert. for Clostridium Difficile and Enterocolitis, Pseudomembranous. Completed, enrolled 403 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether a bundle of measures specifically designed for patients with ICD and applied by and Infectious Diseases expert during a year period (2017) will improve the prognosis and reduce the rate of recurrence, compared with the baseline phase (2015) in which no intervention was made.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 1, 2016
Enrollment StartFeb 15, 2017
Primary CompletionDec 15, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.7 years ago

Interventions

Systematic evaluation by an ID expert.behavioral

Specific "bundle" of measures: 1. Systematic evaluation of all patients diagnosed with CDI by an Infectious Disease expert To ensure compliance with clinical practice guidelines about specific treatment for CDI, depending on the severity of the episode and the existence of previous episodes and to optimize concomitant antibiotic therapy ("antimicrobial stewardship"). 2. To ensure appropriate monitoring during the period of greatest risk of relapse in order to reduce as far as possible, the number of relapses. Personalized assistance by telephone or by email for early consultation in case of recurrence of symptoms or need for a new antibiotic course.